title: Diagnosis and treatment of prostate cancers in renal-transplant recipients.
abstract: BACKGROUND
  There is no consensus regarding prostate cancer in renal-transplant recipients (RTR). A questionnaire evaluating prostate cancer screening after transplantation and assessing the number, diagnostic modalities, treatment, and outcome of prostate cancer cases was mailed to 22 French renal-transplant centers.
  
  
  RESULTS
  Among 1,680 RTR in 1998, 11 (0.65%) cases of prostate cancer were diagnosed, and among the 2,338 recipients followed up, 28 (1%) cases of prostate cancer have been diagnosed and treated. Median ages at diagnosis and at transplantation were 63 and 58, respectively. Clinical stages were T1 50% and T2 25%. Eighteen patients had a Gleason score under 7. At 18 months of mean follow-up, 2 men had died from prostate cancer, and in the curative treatment group, 16 of 17 men were alive with no evidence of disease.
  
  
  CONCLUSIONS
  The incidence of prostate cancer in RTR appeared to be higher than expected. Prostate specific antigen (PSA) testing should be performed routinely each year in renal transplantation centers.
authors.affiliation: Renal Transplantation Committee of the French Urological Association, Paris, France.
authors.forename: Luc
authors.initials: L
authors.lastname: Cormier
authors.forename: Eric
authors.initials: E
authors.lastname: Lechevallier
authors.forename: Benoit
authors.initials: B
authors.lastname: Barrou
authors.forename: Gérard
authors.initials: G
authors.lastname: Benoit
authors.forename: Henri
authors.initials: H
authors.lastname: Bensadoun
authors.forename: Karim
authors.initials: K
authors.lastname: Boudjema
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Descottes
authors.forename: Bertrand
authors.initials: B
authors.lastname: Doré
authors.forename: Laurent
authors.initials: L
authors.lastname: Guy
authors.forename: Bernard
authors.initials: B
authors.lastname: Malavaud
authors.forename: Xavier
authors.initials: X
authors.lastname: Martin
authors.forename: Jean Jacques
authors.initials: JJ
authors.lastname: Patard
authors.forename: Jacques
authors.initials: J
authors.lastname: Petit
authors.forename: Laurent
authors.initials: L
authors.lastname: Salomon
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D015994:Incidence; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000453:epidemiology* / Q000209:etiology